- Home
- OPTN vs JMM Comparison
OPTN vs JMM Comparison
Compare OPTN & JMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPTN
- JMM
- Stock Information
- Founded
- OPTN 2010
- JMM 1988
- Country
- OPTN United States
- JMM United States
- Employees
- OPTN N/A
- JMM N/A
- Industry
- OPTN Biotechnology: Pharmaceutical Preparations
- JMM Trusts Except Educational Religious and Charitable
- Sector
- OPTN Health Care
- JMM Finance
- Exchange
- OPTN Nasdaq
- JMM Nasdaq
- Market Cap
- OPTN 55.4M
- JMM 58.2M
- IPO Year
- OPTN 2017
- JMM N/A
- Fundamental
- Price
- OPTN $9.17
- JMM $6.04
- Analyst Decision
- OPTN Hold
- JMM
- Analyst Count
- OPTN 3
- JMM 0
- Target Price
- OPTN $9.00
- JMM N/A
- AVG Volume (30 Days)
- OPTN 141.6K
- JMM 16.1K
- Earning Date
- OPTN 05-13-2025
- JMM 01-01-0001
- Dividend Yield
- OPTN N/A
- JMM 5.44%
- EPS Growth
- OPTN N/A
- JMM N/A
- EPS
- OPTN N/A
- JMM N/A
- Revenue
- OPTN $78,226,000.00
- JMM N/A
- Revenue This Year
- OPTN $30.49
- JMM N/A
- Revenue Next Year
- OPTN $13.51
- JMM N/A
- P/E Ratio
- OPTN N/A
- JMM N/A
- Revenue Growth
- OPTN 10.20
- JMM N/A
- 52 Week Low
- OPTN $4.82
- JMM $5.29
- 52 Week High
- OPTN $20.03
- JMM $6.10
- Technical
- Relative Strength Index (RSI)
- OPTN 76.77
- JMM 48.95
- Support Level
- OPTN $8.75
- JMM $5.83
- Resistance Level
- OPTN $9.28
- JMM $5.96
- Average True Range (ATR)
- OPTN 0.14
- JMM 0.14
- MACD
- OPTN -0.11
- JMM -0.01
- Stochastic Oscillator
- OPTN 79.25
- JMM 58.06
About OPTN OptiNose Inc.
OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.
About JMM Nuveen Multi-Market Income Fund (MA)
Nuveen Multi-Market Income Fund is a United States-based closed-end management investment company. The investment objective of the company is to provide high monthly income consistent with prudent risk to capital. The fund predominantly invests in debt securities including, but not limited to residential and commercial mortgage-backed securities, asset-backed securities, corporate debt obligations, convertible debt securities, U.S. government securities, and other such fixed income instruments. It may also invest in preferred stocks.